Pancreatic Disorders News

The prevalence of pathogenic germline variants associated with pancreatic ductal adenocarcinoma and limitations of current methods to determine testing eligibility may warrant universal germline genetic testing at the time of diagnosis, according to a study of a consecutive cohort.

ASCO released updated recommendations that incorporate new evidence related to second-line therapy for patients with metastatic pancreatic cancer who progressed on or experienced intolerable toxicity during first-line therapy.

Higher levels of branched-chain amino acids in the blood correlated with a higher risk for pancreatic cancer, according to research published in Gastroenterology.

Researchers identified mutations in six genes associated with pancreatic cancer, according to study results published in JAMA.

CHICAGO — Aron Knickerbocker, MBA, CEO of Five Prime Therapeutics, spoke with HemOnc Today at ASCO Annual Meeting about advances in the company’s oncology program.

WASHINGTON — In this exclusive video perspective from Digestive Disease Week 2018, Christopher J. DiMaio, MD, from the Icahn School of Medicine at Mount Sinai in New York, discusses results of a study that examined EUS-guided microforceps biopsy for the diagnosis of pancreatic cystic lesions.

CHICAGO — Preoperative chemotherapy with radiation demonstrated a significant survival benefit compared with surgery alone among patients with borderline resectable pancreatic cancer, according to preliminary results of the phase 3 randomized controlled PREOPANC trial presented at the ASCO Annual Meeting.

Researchers at Binghamton University and CPSI Biotech have developed a novel technique that uses cryotherapy and hyperthermia therapy to attack pancreatic cancer cells.

The microbial population in the pancreas may provide information about the development of pancreatic cancer, according to research conducted at New York University.

An increased risk for acute pancreatitis among ethnic minorities was associated with very high levels of triglycerides, especially in those with alcohol abuse and gallstones, according to new research published in Endocrine Practice.